PPP1R3B
Basic information
Region (hg38): 8:9136255-9151574
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PPP1R3B gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 18 | 19 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 18 | 1 | 0 |
Variants in PPP1R3B
This is a list of pathogenic ClinVar variants found in the PPP1R3B region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
8-9140816-T-C | not specified | Uncertain significance (Dec 15, 2023) | ||
8-9140936-G-T | not specified | Uncertain significance (Jan 31, 2024) | ||
8-9140997-G-C | not specified | Uncertain significance (Jun 23, 2021) | ||
8-9141009-C-G | not specified | Uncertain significance (Jun 10, 2022) | ||
8-9141054-C-T | not specified | Uncertain significance (Jul 27, 2021) | ||
8-9141134-G-A | Uncertain significance (Mar 05, 2018) | |||
8-9141164-C-T | not specified | Uncertain significance (Aug 21, 2023) | ||
8-9141174-C-A | not specified | Uncertain significance (Dec 03, 2021) | ||
8-9141183-C-G | not specified | Uncertain significance (Mar 25, 2024) | ||
8-9141227-T-G | not specified | Uncertain significance (Oct 03, 2022) | ||
8-9141229-C-A | not specified | Uncertain significance (May 16, 2022) | ||
8-9141258-G-A | not specified | Uncertain significance (Dec 21, 2023) | ||
8-9141261-C-T | not specified | Likely benign (Jan 26, 2022) | ||
8-9141293-T-C | not specified | Uncertain significance (Oct 05, 2023) | ||
8-9141304-C-G | not specified | Uncertain significance (Oct 26, 2022) | ||
8-9141398-G-A | not specified | Uncertain significance (Apr 06, 2023) | ||
8-9141405-C-T | not specified | Uncertain significance (Jun 09, 2022) | ||
8-9141565-C-A | not specified | Uncertain significance (Nov 30, 2022) | ||
8-9141575-A-C | not specified | Uncertain significance (Jul 25, 2023) | ||
8-9141613-C-T | not specified | Uncertain significance (Dec 21, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PPP1R3B | protein_coding | protein_coding | ENST00000310455 | 1 | 15320 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0650 | 0.877 | 125733 | 0 | 15 | 125748 | 0.0000596 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -1.11 | 198 | 159 | 1.25 | 0.00000988 | 1898 |
Missense in Polyphen | 54 | 55.089 | 0.98023 | 689 | ||
Synonymous | -0.869 | 76 | 67.0 | 1.14 | 0.00000509 | 528 |
Loss of Function | 1.60 | 3 | 7.82 | 0.384 | 4.07e-7 | 104 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000181 | 0.000181 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000529 | 0.0000527 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.0000980 | 0.0000980 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Acts as a glycogen-targeting subunit for phosphatase PP1. Facilitates interaction of the PP1 with enzymes of the glycogen metabolism and regulates its activity. Suppresses the rate at which PP1 dephosphorylates (inactivates) glycogen phosphorylase and enhances the rate at which it activates glycogen synthase and therefore limits glycogen breakdown. Its activity is inhibited by PYGL, resulting in inhibition of the glycogen synthase and glycogen phosphorylase phosphatase activities of PP1. Dramatically increases basal and insulin-stimulated glycogen synthesis upon overexpression in hepatocytes (By similarity). {ECO:0000250}.;
- Pathway
- Insulin resistance - Homo sapiens (human);Insulin signaling pathway - Homo sapiens (human)
(Consensus)
Recessive Scores
- pRec
- 0.133
Intolerance Scores
- loftool
- 0.536
- rvis_EVS
- 0.04
- rvis_percentile_EVS
- 56.92
Haploinsufficiency Scores
- pHI
- 0.179
- hipred
- Y
- hipred_score
- 0.568
- ghis
- 0.458
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.293
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ppp1r3b
- Phenotype
- reproductive system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); homeostasis/metabolism phenotype; growth/size/body region phenotype;
Gene ontology
- Biological process
- glycogen metabolic process;regulation of glycogen biosynthetic process;regulation of glycogen catabolic process;protein dephosphorylation;regulation of phosphoprotein phosphatase activity
- Cellular component
- protein phosphatase type 1 complex;glycogen granule;intracellular membrane-bounded organelle
- Molecular function
- protein binding;protein phosphatase regulator activity;enzyme binding;[phosphorylase] phosphatase activity